The research investigates the reasons for declining anti-cancer immunity with age and the observed differences between biological males and females. The study combines mouse experiments and human datasets to examine the impact of age and sex on T cell immunity, immune surveillance, and the recognition of cancer antigens. A key challenge is the limited understanding of why immune capacity diminishes with age and how biological sex interacts with immune aging. The research focused on tracking changes in lymph nodes and the thymus in both male and female mice across their lifespans, assessing the impact on melanoma tumor cells.
Manipulating T cell development and temporarily reducing the effects of male sex hormones on the thymus in middle-aged male mice demonstrated the replenishment of CD8 T cells, improved tumor recognition, and enhanced responses to immune checkpoint blockade. Human data corroborated these findings, revealing differences in lymph node size, age-related thymus shrinkage, and naive CD8 T cell populations between sexes. These findings suggest that age and sex significantly shape the immune environment, potentially impacting cancer outcomes and immunotherapy responses. Maintaining thymic function into adulthood and targeting the thymus as a potential strategy for preserving or restoring anti-cancer immunity are highlighted as emerging trends.